BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Debjit Chattopadhyay does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 SLNOSoleno Therapeutics Inc | Buy | $97.00 | May 2025 | −41.1% | Miss |
 BEAMBeam Therapeutics Inc | Buy | $55.00 | May 2025 | +72.6% | Miss |
 MAZEMaze Therapeutics, Inc. Common Stock | Buy | $19.00 | Apr 2025 | +203.6% | Hit |
| SLNOSoleno Therapeutics Inc | Buy | $81.00 | Mar 2025 | −57.7% | Hit |
 CNTACentessa Pharmaceuticals PLC ADR | Buy | $28.00 | Mar 2025 | +100.3% | Hit |
| BEAMBeam Therapeutics Inc | Buy | $78.00 | Feb 2025 | −1.4% | Miss |
| MAZEMaze Therapeutics, Inc. Common Stock | Buy | $19.00 | Feb 2025 | +295.0% | Hit |
 RZLTRezolute Inc | Buy | — | Feb 2025 | −44.0% | — |
| CNTACentessa Pharmaceuticals PLC ADR | Buy | — | Feb 2025 | +28.2% | — |
 BNTCBenitec Biopharma Ltd ADR | Buy | $17.00 | Dec 2024 | +20.1% | Hit |
| CNTACentessa Pharmaceuticals PLC ADR | Buy | $28.00 | Nov 2024 | +60.9% | Miss |
| BNTCBenitec Biopharma Ltd ADR | Buy | $17.00 | Sep 2024 | +80.0% | Hit |
| RZLTRezolute Inc | Buy | $11.00 | Aug 2024 | +64.8% | Miss |
 DTILPrecision BioSciences Inc | Buy | $19.00 | Apr 2024 | −47.7% | Miss |
 VYGRVoyager Therapeutics Inc | Buy | $22.00 | Mar 2024 | −61.5% | Miss |
| SLNOSoleno Therapeutics Inc | Buy | $40.00 | Nov 2023 | +84.5% | Hit |
 PASGPassage Bio Inc | Buy | $11.00 | Nov 2022 | −56.3% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.